AG
SLRN

Artal Group’s ACELYRIN SLRN Stock Holding History

Artal Group’s Portfolio SLRN Stock Details SLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,020,888
Closed -$8.91M – 86
2024
Q2 		$8.91M Sell
2,020,888
-384,255
-16% -$1.8M 0.23% 42
2024
Q1 		$16.2M Sell
2,405,143
-630,745
-21% -$4.79M 0.41% 31
2023
Q4 		$22.6M Buy
3,035,888
+566,609
+23% +$4.84M 0.75% 20
2023
Q3 		$25.1M Buy
2,469,279
+648,065
+36% +$13.8M 1.08% 15
2023
Q2 		$38.1M Buy
+1,821,214
New +$37.2M 1.18% 16

Other funds holding SLRN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
ACMC
AyurMaya Capital Management Company Portsmouth, New Hampshire $426M AUM 838% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
GA
General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return

Artal Group's SLRN Position: Q3 2024 in Review

Artal Group sold out of ACELYRIN (SLRN) in Q3 2024, closing a stake of 2,020,888 shares — an estimated $8.91M sold.

Artal Group first reported a position in SLRN in Q2 2023 and held it in 5 quarters. The position peaked at $38.1M in Q2 2023. 122 funds tracked by Wall St. Rank hold SLRN as of Q3 2024.

  • Artal Group reported no remaining ACELYRIN position as of Q3 2024 after selling out during the quarter.
  • Artal Group sold 2,020,888 ACELYRIN shares in Q3 2024, an estimated $8.91M.
  • Artal Group first reported a position in ACELYRIN in Q2 2023 and held it in 5 quarters.
  • Artal Group's ACELYRIN position peaked at $38.1M in Q2 2023.
  • 122 funds tracked by Wall St. Rank held ACELYRIN as of Q3 2024.

Based on Artal Group's 13F filing for Q3 2024, filed 13 Nov 2024.